Rexrode K M, Buring J E, Manson J E
Division of Preventive Medicine, Boston, Massachusetts 02215, USA.
Int J Obes Relat Metab Disord. 2001 Jul;25(7):1047-56. doi: 10.1038/sj.ijo.0801615.
Waist circumference is a simpler measure of abdominal adiposity than waist/hip ratio (WHR), but few studies have directly compared the two measures as predictors of coronary heart disease (CHD) in men. In addition, whether the association of abdominal adiposity is independent of total adiposity as measured by body mass index (BMI) in men remains uncertain.
To compare waist circumference and WHR as predictors of CHD in men, and to determine whether the association is independent of BMI.
Prospective cohort study.
We compared WHR, waist circumference and BMI with risk of CHD (myocardial infarction or coronary revascularization) among men in the Physicians' Health Study, a randomized trial of aspirin and beta-carotene among 22 071 apparently healthy US male physicians, aged 40-84 y at baseline in 1982. Men reported height at baseline, and weight, waist and hip measurements on the 9 y follow-up questionnaire.
Among the 16 164 men who reported anthropometric measurements and were free from prior CHD, stroke or cancer, a total of 552 subsequent CHD events occurred during an average follow-up of 3.9 y. After adjusting for age, randomized study agent, smoking, physical activity, parental history of myocardial infarction, alcohol intake, multivitamin and aspirin use, men in the highest WHR quintile (>or=0.99) had a relative risk (RR) for CHD of 1.50 (95% CI 1.14-1.98) compared with those in the lowest quintile (<0.90). Men in the highest waist circumference quintile (>or=103.6 cm) had a RR of 1.60 (CI, 1.21-2.11) for CHD compared with men in the lowest quintile (<88.4 cm). Further adjustment for BMI substantially attenuated these associations: men in the highest WHR and waist circumference quintiles had relative risks for CHD of 1.23 (CI, 0.92-1.66) and 1.06 (CI, 0.74-1.53), respectively. Men in the highest BMI quintile (>or=27.6 kg/m(2)) had a multivariate RR of CHD of 1.73 (CI, 1.29-2.32), after adjustment for WHR. No significant effect modification by age of the relationship between either measure of abdominal adiposity and risk of CHD was observed.
These data support a modest relationship between abdominal adiposity, as measured by either WHR or waist circumference, and risk of CHD both in middle-aged and older men. However, abdominal adiposity did not remain an independent predictor of CHD after adjustment for BMI.
腰围是比腰臀比(WHR)更简单的腹部肥胖测量指标,但很少有研究直接比较这两种指标作为男性冠心病(CHD)预测指标的情况。此外,男性腹部肥胖与通过体重指数(BMI)测量的总体肥胖之间的关联是否独立尚不确定。
比较腰围和WHR作为男性CHD预测指标,并确定这种关联是否独立于BMI。
前瞻性队列研究。
在医生健康研究中,我们比较了WHR、腰围和BMI与CHD风险(心肌梗死或冠状动脉血运重建)之间的关系。该研究是一项针对22071名表面健康的美国男性医生进行的阿司匹林和β-胡萝卜素随机试验,这些医生在1982年基线时年龄为40 - 84岁。男性在基线时报告身高,并在9年随访问卷中报告体重、腰围和臀围测量值。
在16164名报告了人体测量数据且无既往CHD、中风或癌症的男性中,在平均3.9年的随访期间共发生了552例后续CHD事件。在调整年龄、随机研究药物、吸烟、身体活动、心肌梗死家族史、饮酒、多种维生素和阿司匹林使用情况后,WHR最高五分位数(≥0.99)的男性患CHD的相对风险(RR)为1.50(95%CI 1.14 - 1.98),而最低五分位数(<0.90)的男性为参照。腰围最高五分位数(≥103.6 cm)的男性患CHD的RR为1.60(CI,1.21 - 2.11),而最低五分位数(<88.4 cm)的男性为参照。进一步调整BMI后,这些关联显著减弱:WHR和腰围最高五分位数的男性患CHD的相对风险分别为1.23(CI,0.92 - 1.66)和1.06(CI,0.74 - 1.53)。BMI最高五分位数(≥27.6 kg/m²)的男性在调整WHR后患CHD的多变量RR为1.73(CI,1.29 - 2.32)。未观察到年龄对任何一种腹部肥胖测量指标与CHD风险之间关系的显著效应修正。
这些数据支持通过WHR或腰围测量的腹部肥胖与中年及老年男性CHD风险之间存在适度关联。然而,在调整BMI后,腹部肥胖不再是CHD的独立预测指标。